A cell encapsulation device for studying soluble factor release from cells transplanted in the rat brain.
The transplantation of a variety of naturally occurring and genetically modified cell types has been shown to be an effective experimental method to achieve sustained delivery of therapeutic molecules to specific target areas in the brain. To acquire a better understanding of dosing, implant mechanism of action, and how certain cell types affect remodeling of central nervous system (CNS) tissue, a refillable cell encapsulation device was developed for introducing cells into the brain while keeping them physically isolated from contact with brain tissue with a semipermeable membrane. The stereotactically placed device consists of a hollow fiber membrane (HFM), a polyurethane grommet with watertight cap that snaps into a precisely drilled hole in the rat skull, and a removable cell-containing insert. The cell-containing insert can be introduced or removed in a time-dependent manner to study the influence of soluble factors released from transplanted cells. The study describes the device design and validates its utility using a well-established cell transplantation model of Parkinson's disease.
Kim
Young-Tae
YT
The Keck Center for Tissue Engineering, Department of Bioengineering, 20 South 2030 East Building 570, Rm. 108D, University of Utah, Salt Lake City, UT 84112, USA.
Hitchcock
Robert
R
Broadhead
Kelly W
KW
Messina
Darin J
DJ
Tresco
Patrick A
PA
D000818:Animals; D001921:Brain / Q000166:cytology* / Q000201:enzymology / Q000601:surgery; D002452:Cell Count / Q000379:methods; D017690:Cell Transplantation / Q000295:instrumentation* / Q000379:methods*; D008297:Male; D008567:Membranes, Artificial; D016716:PC12 Cells; D010539:Permeability; D051381:Rats; D045442:Rotarod Performance Test; D012995:Solubility; D013238:Stereotaxic Techniques; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D008567:Membranes, Artificial; D014446:Tyrosine 3-Monooxygenase